抗生素驱动和微生物群向治疗用于肺高血压的高级管理
Yue Xing1,2, Chunli Liu1, Chenting Zhang1
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangdong Key Laboratory of Vascular Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangdong, Guangzhou, China.
Respiratory research
|November 1, 2025
概括
抗生素治疗可以通过改变肠道细菌来帮助降低肺高血压 (PH),特别是在与肺部疾病相关的病例中. 对PH优化抗生素治疗的进一步研究是有必要的.
科学领域:
- 肺高血压研究 肺高血压研究
- 微生物组和疾病
- 药理干预药理干预
背景情况:
- 肺高血压 (PH),特别是慢性阻塞性肺病 (COPD) 的次要,缺乏向治疗.
- 微生物群失衡越来越多地与PH进展有关.
- 这项研究调查了抗生素作为潜在的微生物向性干预PH.
研究的目的:
- 探索抗生素在调节肠道微生物群和改善肺高血压中的作用.
- 评估抗生素治疗对PH患者肺动脉平均压力 (mPAP) 的影响.
- 为了研究抗生素对血液动力学和肺血管重塑在低氧诱导的PH大鼠模型的作用.
主要方法:
- 针对mPAP治疗后发生的变化,对MIMIC数据库的回顾性分析.
- 220名PH患者 (组1,3,4) 的临床数据和16S rRNA测序,以分析微生物群组成.
- 低氧诱导的PH大鼠模型,以评估抗生素对血液动力学,血管重塑和肠道微生物群的影响.
主要成果:
- 抗生素使用与PH患者的mPAP降低相关,特别是缺氧PH.
- 微生物群的多样性减少,但有益的物种,如乳酸菌丰富.
- 抗生素减弱了RVSP,减少了肺血管加厚,并保持了大鼠的肠道完整性;乳杆菌和Anaerostipes显示了保护性相关性.
结论:
- 抗生素诱导的微生物群调节可以通过向失生症和炎症来缓解PH.
- 这些发现支持探索针对PH的优化抗生素疗法,特别是在低氧性肺病相关病例中.
- 建议进一步研究针对PH的微生物向疗法.
相关概念视频
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
426
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
426
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
433
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
433
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
450
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
450
01:28Pneumonia IV: Management
742
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
742
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
578
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
578
01:28Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532